Get started
Author

Maureen Oliveira

Mapping the human genetic architecture of COVID-19
2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 970
Whole-genome sequencing reveals host factors underlying critical COVID-19
2022 · Athanasios Kousathanas, Erola Pairo-Castineira, et al. · Nature · 331
PDF
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors
2003 · Bluma Brenner, Dan Turner, et al. · AIDS · 308
Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir
2011 · Peter K. Quashie, Thibault Mesplède, et al. · Journal of Virology · 240
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture
2006 · Bluma G Brenner, Maureen Oliveira, et al. · AIDS · 224
Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection
2002 · Bluma G. Brenner, Jean-Pierre Routy, et al. · Journal of Virology · 216
A first update on mapping the human genetic architecture of COVID-19
2022 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics Initiative, et al. · Nature · 175
PDF
Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT
2002 · Hugues Loemba, Bluma Brenner, et al. · Antimicrobial Agents and Chemotherapy · 128
A second update on mapping the human genetic architecture of COVID-19
2023 · The COVID-19 Host Genetics Initiative, Leadership, et al. · Nature · 125
PDF
Transmission networks of drug resistance acquired in primary/early stage HIV infection
2008 · Bluma G Brenner, Michel Roger, et al. · AIDS · 124
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir
2018 · the Montreal Primary HIV (PHI) Cohort Study Group, Maureen Oliveira, et al. · Retrovirology · 120
PDF
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection
2004 · Bluma Brenner, Jean-Pierre Routy, et al. · AIDS · 118
High Prevalence of the K65R Mutation in Human Immunodeficiency Virus Type 1 Subtype C Isolates from Infected Patients in Botswana Treated with Didanosine-Based Regimens
2006 · Florence Doualla-Bell, Ava Avalos, et al. · Antimicrobial Agents and Chemotherapy · 110
Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations
2011 · Hong-Tao Xu, Eugene L. Asahchop, et al. · Journal of Virology · 98
Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation HIV-1 Integrase Inhibitor
2010 · Tamara Bar-Magen, Richard D. Sloan, et al. · Journal of Virology · 91
Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1
2008 · Dimitrios Coutsinos, Cédric F. Invernizzi, et al. · Journal of Virology · 88
Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication #
2017 · Hong-Tao Xu, Susan P. Colby-Germinario, et al. · Scientific Reports · 74
PDF
Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors
2016 · Bluma G. Brenner, Réjean Thomas, et al. · Journal of Antimicrobial Chemotherapy · 72
PDF
Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors
2016 · Hong-Tao Xu, Said A. Hassounah, et al. · Journal of Antimicrobial Chemotherapy · 68
PDF
Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine
2013 · Hong-Tao Xu, Susan P. Colby-Germinario, et al. · Antimicrobial Agents and Chemotherapy · 68
Modulation of Stress Protein (hsp27 and hsp70) Expression in CD4+ Lymphocytic Cells Following Acute Infection with Human Immunodeficiency Virus Type-1
1997 · Zev Wainberg, Maureen Oliveira, et al. · Virology · 68
PDF
Natural Polymorphisms in the Human Immunodeficiency Virus Type 2 Protease Can Accelerate Time to Development of Resistance to Protease Inhibitors
2006 · Michel Ntemgwa, Bluma G. Brenner, et al. · Antimicrobial Agents and Chemotherapy · 66
Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV‐1 Subtype C
2009 · Cédric F. Invernizzi, Dimitrios Coutsinos, et al. · The Journal of Infectious Diseases · 64
Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes
2010 · Eugene L. Asahchop, Maureen Oliveira, et al. · Antimicrobial Agents and Chemotherapy · 56
PDF
Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors
2014 · Maureen Oliveira, Thibault Mesplède, et al. · AIDS · 55
Works count: 122
Citation count: 5,653
H-index: 38
I10-index: 85
Year
Topic
Type